Joseph Wagner
Net worth: - $ as of 2024-04-29
Joseph Wagner active positions
| Companies | Position | Start | End |
|---|
Career history of Joseph Wagner
Former positions of Joseph Wagner
| Companies | Position | Start | End |
|---|---|---|---|
| BRIACELL THERAPEUTICS CORP. | Director/Board Member | 2015-05-31 | 2016-03-23 |
| Chief Executive Officer | 2015-05-31 | 2016-03-23 | |
| President | 2015-05-31 | 2016-03-23 | |
Neuronyx, Inc.
 Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Corporate Officer/Principal | - | 2009-10-12 |
Cell Targeting, Inc.
 Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | President | - | - |
| ONCOCYTE CORPORATION | Chief Executive Officer | - | - |
Training of Joseph Wagner
| Duke University School of Medicine | Doctorate Degree |
| Rochester Christian University | Undergraduate Degree |
Statistics
International
| United States | 6 |
| Canada | 2 |
Operational
| Chief Executive Officer | 2 |
| President | 2 |
| Corporate Officer/Principal | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| BRIACELL THERAPEUTICS CORP. | Health Technology |
| Private companies | 2 |
|---|---|
Neuronyx, Inc.
Neuronyx, Inc. Medical SpecialtiesHealth Technology Neuronyx, Inc. develops and distributes bone marrow derived stem cells. It also develops cellular therapies focusing on ischemic diseases to repair damaged cardiac tissues in patients suffering from heart attack. The company was founded by Hubert J.P. Schoemaker in 1999 and is located in Malvern, PA. | Health Technology |
Cell Targeting, Inc.
Cell Targeting, Inc. BiotechnologyHealth Technology Part of Lineage Cell Therapeutics, Inc., Cell Targeting, Inc. is a company that provides research and development of aqueous-based synthetic solutions. The company is based in Cleveland, OH. Cell Targeting was acquired by Lineage Cell Therapeutics, Inc. on January 28, 2011 for $2.38 million. | Health Technology |
- Stock Market
- Insiders
- Joseph Wagner
- Experience
